{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:28:10Z","timestamp":1793410090235,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Austrian Science FundAustrian Science Fund (FWF)","award":["SFB54-P04"],"award-info":[{"award-number":["SFB54-P04"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.thromres.2015.11.002","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T03:09:25Z","timestamp":1447124965000},"page":"196-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent"],"prefix":"10.1016","volume":"137","author":[{"given":"Petra","family":"Jilma-Stohlawetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Schima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stoiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Steinlechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Felli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.11.002_bb0005","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1538-7836.2005.01369.x","article-title":"von Willebrand factor: two sides of a coin","volume":"3","author":"Sadler","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.thromres.2015.11.002_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V58.2.387.387","article-title":"Effect of multimeric structure of the factor viii\/von willebrand factor protein on binding to platelets","volume":"58","author":"Gralnick","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.11.002_bb0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1160\/TH11-12-0803","article-title":"Changes in von Willebrand factor-cleaving protease (adamts-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty","volume":"108","author":"Bander","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1160\/TH10-10-0634","article-title":"von Willebrand factor abnormalities in aortic valve stenosis: pathophysiology and impact on bleeding","volume":"106","author":"Casonato","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1160\/TH09-06-0391","article-title":"Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis","volume":"103","author":"Panzer","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0035","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2011.01.052","article-title":"Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion","volume":"91","author":"Steinlechner","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.athoracsur.2008.10.027","article-title":"Platelet dysfunction in outpatients with left ventricular assist devices","volume":"87","author":"Steinlechner","year":"2009","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2015.11.002_bb0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.healun.2010.01.011","article-title":"Clinical management of continuous-flow left ventricular assist devices in advanced heart failure","volume":"29","author":"Slaughter","year":"2010","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.thromres.2015.11.002_bb0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12265-010-9222-6","article-title":"Hematologic effects of continuous flow left ventricular assist devices","volume":"3","author":"Slaughter","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.thromres.2015.11.002_bb0060","first-page":"II227","article-title":"Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation","volume":"94","author":"Livingston","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2015.11.002_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2010.02.003","article-title":"Post-operative heparin may not be required for transitioning patients with a heartmate ii left ventricular assist system to long-term warfarin therapy","volume":"29","author":"Slaughter","year":"2010","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.thromres.2015.11.002_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1010-7940(00)00334-1","article-title":"Effect of high dose platelet inhibitor treatment on thromboembolism in novacor patients","volume":"17","author":"Schmid","year":"2000","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtcvs.2008.07.032","article-title":"Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices","volume":"137","author":"Crow","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2013.02.006","article-title":"Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: heartmate ii and circulite synergy pocket micro-pump","volume":"32","author":"Goda","year":"2013","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.thromres.2015.11.002_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase i\/ii trial of the von Willebrand factor inhibiting aptamer arc1779 in patients with congenital thrombotic thrombocytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1160\/th14-02-0148","article-title":"Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices","volume":"112","author":"Rauch","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1160\/TH11-12-0889","article-title":"The anti-von Willebrand factor aptamer arc1779 increases von Willebrand factor levels and platelet counts in patients with type 2b von Willebrand disease","volume":"108","author":"Jilma-Stohlawetz","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH10-08-0530","article-title":"Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trial","volume":"105","author":"Spiel","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2002-03-0814","article-title":"Changes in von Willebrand factor-cleaving protease (adamts13) activity after infusion of desmopressin","volume":"101","author":"Reiter","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.11.002_bb0110","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1160\/TH04-08-0467","article-title":"Changes in adamts13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation","volume":"93","author":"Reiter","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0115","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1160\/TH14-09-0731","article-title":"Vwf excess and adamts13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in dic, malaria, and ttp","volume":"113","author":"Schwameis","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0120","article-title":"Insights into the mechanism(s) of von Willebrand factor degradation during mechanical circulatory support","author":"Bartoli","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/CIRCHEARTFAILURE.109.877597","article-title":"Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device","volume":"3","author":"Meyer","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.thromres.2015.11.002_bb0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MAT.0b013e3181e5de0a","article-title":"Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients","volume":"56","author":"Crow","year":"2010","journal-title":"ASAIO J."},{"key":"10.1016\/j.thromres.2015.11.002_bb0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jtcvs.2014.09.031","article-title":"Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage","volume":"149","author":"Bartoli","year":"2015","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0140","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.thromres.2014.03.024","article-title":"High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by adamts13","volume":"133","author":"Kragh","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2015.11.002_bb0145","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (heartmate II)","volume":"53","author":"Klovaite","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2015.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.athoracsur.2010.04.099","article-title":"Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients","volume":"90","author":"Crow","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2015.11.002_bb0160","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2015.11.002_bb0165","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1538-7836.2009.03640.x","article-title":"Shear-induced unfolding activates von Willebrand factor a2 domain for proteolysis","volume":"7","author":"Baldauf","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0170","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/eurheartj\/ehu381","article-title":"Post-transcriptional modification of pro-bnp in heart failure: is glycosylation and circulating furin key for cardiovascular homeostasis?","volume":"35","author":"Ichiki","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2015.11.002_bb0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cardiores.2004.04.001","article-title":"Defective glycosylation of calsequestrin in heart failure","volume":"63","author":"Kiarash","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2015.11.002_bb0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jth.12451","article-title":"The o-linked glycans of human von Willebrand factor modulate its interaction with adamts-13","volume":"12","author":"Nowak","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2015.11.002_bb0185","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2007-06-095042","article-title":"N-linked glycosylation of vwf modulates its interaction with adamts13","volume":"111","author":"McKinnon","year":"2008","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481530178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481530178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T04:46:46Z","timestamp":1599799606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481530178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":37,"alternative-id":["S004938481530178X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.11.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}